Log In
Print
BCIQ
Print
Print this Print this
 

CCX140

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionInhibitor of CC chemokine receptor 2 (CCR2; CD192)
Molecular Target CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today